N-CBZ-4-哌啶甲醇(1-CBZ-4-羟甲基哌啶), 98%,Benzyl 4-(hydroxymethyl)piperidine-1-carboxylate
产品编号:西域试剂-WR129907| CAS NO:122860-33-7| 分子式:C14H19NO3| 分子量:249.31
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
英文名称 | Benzyl 4-(hydroxymethyl)piperidine-1-carboxylate |
---|---|
CAS编号 | 122860-33-7 |
产品沸点 | 396.4±25.0 °C at 760 mmHg |
产品密度 | 1.2±0.1 g/cm3 |
产品闪点 | 193.5±23.2 °C |
精确质量 | 249.136490 |
PSA | 49.77000 |
LogP | 1.50 |
蒸气压 | 0.0±1.0 mmHg at 25°C |
折射率 | 1.550 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
危害码 (欧洲) | Xi: Irritant; |
---|---|
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | 26-36/37/39-37/39 |
海关编码 | 2933399090 |
Synonym:4-Hydroxymethylpiperidine-1-carboxylic acid benzyl este Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Potential Health Effects Eye: Causes eye irritation. Skin: Causes skin irritation. May be harmful if absorbed through the skin. Ingestion: May cause irritation of the digestive tract. May be harmful if swallowed. Inhalation: Causes respiratory tract irritation. May be harmful if inhaled. Chronic: Not available. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Section 7 - HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 122860-33-7: Personal Protective Equipment Eyes: Not available. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Viscous liquid Color: yellow Odor: pleasant odor pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: Not available. Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Not available. Solubility in water: Specific Gravity/Density: Molecular Formula: C14H19NO3 Molecular Weight: 249 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Not available. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: Oxidizing agents, acid chlorides. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, carbon dioxide, acrid smoke and fumes. Hazardous Polymerization: Has not been reported. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 122860-33-7 unlisted. LD50/LC50: Not available. Carcinogenicity: Benzyl 4-(hydroxymethyl)tetrahydro-1(2H)-pyridinecarboxylate - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA No information available. IMO No information available. RID/ADR No information available. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XI Risk Phrases: R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 37/39 Wear suitable gloves and eye/face protection. WGK (Water Danger/Protection) CAS# 122860-33-7: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 122860-33-7 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 122860-33-7 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
~90% ![]() 122860-33-7 |
文献:INSTITUT PASTEUR KOREA; KIM, Junwon; CECHETTO, Jonathan; NO, Zaesung; CHRISTOPHE, Thierry; KIM, Taehee; NAM, Ji, Youn; SO, Wonyoung; JO, Mina; OK, Taedong; PARK, Changmin; SEO, Min, Jung; SOHN, Jeong-Hun; SOMMER, Peter; BOESE, Annette, Sophia; HAN, Sung-Jun; PARK, Young, Sam; KIM, Hwa, Pyung Patent: WO2010/46780 A2, 2010 ; Location in patent: Page/Page column 63-64 ; |
~44% ![]() 122860-33-7 |
文献:SmithKline Beecham plc Patent: EP1051413 B1, 2003 ; |
~45% ![]() 122860-33-7 |
文献:Fang, Xinqin; Garvey, David S.; Gaston, Ricky D.; Lin, Chia-En; Ranatunga, Ramani R.; Richardson, Stewart K.; Wang, Tiansheng; Wang, Weiheng; Wey, Shiow-Jyi Patent: US2003/203915 A1, 2003 ; |
~91% ![]() 122860-33-7 |
文献:Sterling Winthrop Inc. Patent: US5512589 A1, 1996 ; US 5512589 A |
~% ![]() 122860-33-7 |
文献:Journal of Medicinal Chemistry, , vol. 48, # 10 p. 3586 - 3604 |
~% ![]() 122860-33-7 |
文献:US4968704 A1, ; |
~% ![]() 122860-33-7 |
文献:Chinese Chemical Letters, , vol. 23, # 6 p. 661 - 664 |
~85% ![]() 122860-33-7 |
文献:NEUROSEARCH A/S Patent: WO2007/93603 A1, 2007 ; Location in patent: Page/Page column 15 ; WO 2007/093603 A1 |
~% ![]() 122860-33-7 |
文献:Tetrahedron Letters, , vol. 48, # 2 p. 199 - 202 |
上游产品 9 | |
---|---|
下游产品 8 | |